SMN1 and neurodegenerative disease: Therefore, the Wnt/β-catenin signaling pathway is an appealing target for neurodegenerative disease treatment since abnormal regulation of the pathway is closely linked to a variety of neurodegenerative diseases, including AD, PD, HD, SMA, MS, and ALS.